Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMauris is a private software company that provides a cloud-based seed-to-retail and point-of-sale platform for the regulated cannabis market, with particular relevance to medical cannabis program administration. The company built its platform on Salesforce and markets capabilities including inventory tracking, fulfillment, retail operations, reporting, payment processing, and patient-related workflow support. BioMauris became notable for winning and implementing Iowa's medical cannabidiol tracking system contract in 2018. Although it references experience in biotech and pharmaceutical sectors and supports healthcare-adjacent workflows, BioMauris appears to be primarily a healthcare/cannabis software vendor rather than a drug developer, biotech, or pharma company. Its business is centered on compliant data management and operational infrastructure rather than a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMauris.